Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1997-12-18
|
pubmed:abstractText |
We evaluated S-100 levels in paired cerebrospinal fluid (CSF) and serum samples in a group of 135 patients referred to the German Creutzfeldt-Jakob disease (CJD) surveillance unit from June 1993 to May 1995. The patients were seen in a prospective case control study. The diagnosis of probable CJD during life was made in any patient presenting with rapidly progressive dementia of less than 2 years' duration, typical periodic sharp wave complexes (PSWCs) in the EEG and at least two of the following findings: myoclonus, visual/or cerebellar symptoms, pyramidal and/or extrapyramidal signs and/or akinetic mutism. Patients presenting with the above clinical signs and symptoms but without PSWCs were classified as possible, while those with a dementia of a duration exceeding 2 years and without PSWCs were classified as other. S-100 was determined in paired CSF and serum samples by a commercially available enzyme-linked immunosorbent assay. In a group of 76 patients with definite and probable CJD, S-100 concentration (median 25 ng/ml, range 2-117) in CSF was significantly higher (P < 0.0001) than in 32 patients diagnosed as other (median 4 ng/ml, range 1-19). Serum levels of S-100 were below 0.5 ng/ml in all groups. At a cut-off of 8 ng/ml an optimum sensitivity of 84.2% with a specificity of 90.6% for the diagnosis of CJD by the determination of S-100 in CSF is obtained. S-100 levels exceeding 8 ng/ml in CSF support the diagnosis of CJD in any patient presenting with rapidly progressive dementia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0340-5354
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
244
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
566-70
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9352454-Adult,
pubmed-meshheading:9352454-Aged,
pubmed-meshheading:9352454-Aged, 80 and over,
pubmed-meshheading:9352454-Case-Control Studies,
pubmed-meshheading:9352454-Creutzfeldt-Jakob Syndrome,
pubmed-meshheading:9352454-Female,
pubmed-meshheading:9352454-Humans,
pubmed-meshheading:9352454-Male,
pubmed-meshheading:9352454-Middle Aged,
pubmed-meshheading:9352454-Prospective Studies,
pubmed-meshheading:9352454-ROC Curve,
pubmed-meshheading:9352454-S100 Proteins
|
pubmed:year |
1997
|
pubmed:articleTitle |
S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
|
pubmed:affiliation |
Neurologische Klinik und Poliklinik, Georg-August-Universität Göttingen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|